Biohaven (BHVN) is back in focus after using the 2026 American Thyroid Association meeting to showcase new Graves' disease data, highlight international Phase 3 enrollment for BHV-1300, and announce a...
Source LinkBiohaven (BHVN) is back in focus after using the 2026 American Thyroid Association meeting to showcase new Graves' disease data, highlight international Phase 3 enrollment for BHV-1300, and announce a...
Source Link
Comments